WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Henry J. FuchsPresident Worldwide RD2023-03-1636,000$93.41
$3.36MSell
Jean Jacques BienaimeChief Executive Officer2023-03-1688,623$93.41
$8.28MSell
George Eric DavisEVP Chief Legal Officer2023-03-1619,957$93.41
$1.86MSell
Jeffrey Robert AjerEVP Chief Commercial Officer2023-03-1620,510$93.41
$1.92MSell
Brian MuellerEVP Chief Financial Officer2023-03-163,973$93.41
$371.12kSell
Jeffrey Robert AjerEVP Chief Commercial Officer2023-03-153,971$87.74
$348.42kSell
Henry J. FuchsPresident Worldwide RD2023-03-154,799$87.74
$421.06kSell
Jean Jacques BienaimeChief Executive Officer2023-03-159,437$87.74
$828.00kSell
Brian MuellerEVP Chief Financial Officer2023-03-152,708$87.74
$237.60kSell
Charles Greg GuyerEVP Chief Technical Officer2023-03-151,856$87.74
$162.85kSell

1 of 11

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Primecap Management Co9.43%17,580,859$1.61BInstitution
Vanguard Group Inc9.31%17,365,080$1.59BInstitution
Blackrock Inc7.80%14,540,191$1.33BInstitution
Dodge Cox7.71%14,383,663$1.32BInstitution
Baker Bros Advisors LP4.09%7,620,494$698.57MInstitution
Capital Research Global Investors3.03%5,651,001$518.03MInstitution
State Street Corp2.89%5,388,844$494.00MInstitution
Viking Global Investors LP2.83%5,273,620$483.43MInstitution
Ameriprise Financial Inc2.49%4,648,628$426.14MInstitution
Janus Henderson Group PLC2.08%3,888,444$356.45MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN97.63%1.50%Net SellingNet Selling
INCY78.83%21.17%Net SellingNet Buying
ARGX55.26%0.00%
RPRX48.68%16.47%Net SellingNet Selling
SRPT73.25%26.75%Net BuyingNet Selling
View Top Biotech Stocks

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 97.63% institutional shareholders, 1.50% Biomarin Pharmaceutical insiders, and 0.87% retail investors. Primecap Management Co is the largest individual Biomarin Pharmaceutical shareholder, owning 17.58M shares representing 9.43% of the company. Primecap Management Co's Biomarin Pharmaceutical shares are currently valued at $1.62B.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.